SEC 13F Intelligence

Thompson Siegel & Walmsley LLC / ABBV

Thompson Siegel & Walmsley LLC’s Abbvie Inc Position

Does Thompson Siegel & Walmsley LLC own Abbvie Inc (ABBV)? Yes — 74.5K shares worth $16M (+0.28% of its 13F portfolio) as of Q1 2026, up from 74.3K shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
74.5K
% of Portfolio
+0.28%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q1 ’19: $2MQ1 ’19Q2 ’19: $2MQ3 ’19: $3MQ4 ’19: $4MQ1 ’20: $6MQ1 ’20Q2 ’20: $11MQ3 ’20: $7MQ4 ’20: $9MQ1 ’21: $9MQ1 ’21Q2 ’21: $9MQ3 ’21: $9MQ4 ’21: $14MQ1 ’22: $17MQ1 ’22Q2 ’22: $15MQ3 ’22: $10MQ4 ’22: $12MQ1 ’23: $12MQ1 ’23Q2 ’23: $10MQ3 ’23: $11MQ4 ’23: $11MQ1 ’24: $13MQ1 ’24Q2 ’24: $12MQ3 ’24: $14MQ4 ’24: $13MQ1 ’25: $15MQ1 ’25Q2 ’25: $14MQ3 ’25: $17MQ4 ’25: $17MQ1 ’26: $16MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202674.5K$16M+0.28%
Q4 202574.3K$17M+0.28%
Q3 202574.1K$17M+0.28%
Q2 202574.0K$14M+0.23%
Q1 202573.5K$15M+0.26%
Q4 202473.3K$13M+0.20%
Q3 202473.3K$14M+0.22%
Q2 202472.6K$12M+0.20%
Q1 202472.6K$13M+0.20%
Q4 202372.7K$11M+0.18%
Q3 202372.7K$11M+0.18%
Q2 202372.7K$10M+0.16%
Q1 202372.7K$12M+0.19%
Q4 202272.7K$12M+0.19%
Q3 202273.5K$10M+0.17%
Q2 202296.7K$15M+0.24%
Q1 2022103.1K$17M+0.24%
Q4 2021103.1K$14M+0.19%
Q3 202185.6K$9M+0.13%
Q2 202178.5K$9M+0.12%
Q1 202179.9K$9M+0.12%
Q4 202080.8K$9M+0.14%
Q3 202083.2K$7M+0.14%
Q2 2020112.2K$11M+0.22%
Q1 202076.2K$6M+0.14%
Q4 201950.7K$4M+0.07%
Q3 201935.2K$3M+0.04%
Q2 201931.3K$2M+0.03%
Q1 201930.5K$2M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Thompson Siegel & Walmsley LLC’s full portfolio or all institutional holders of ABBV.